# Samra Turajlic
قسمت های برتر پادکست
به روز شده:
samra turajlic is a medical oncologist and cancer researcher. She leads the cancer dynamics lab at the Francis Crick Institute in London, which focuses on understanding how cancers evolve, as well as working as an oncologist at the Royal Marsden.
Her work has revealed that kidney cancers follow a set number of evolutionary paths, each with its own set of genetic changes.
Current biomarkers in immunotherapy
Immunotherapy approaches have revolutionized medical oncology in the last years. However, still only a fraction of patients is responding. Given the risk of side effects without efficacy, therefore, biomarkers providing reliable and reproducible prediction of response are urgently needed. In this p…
Genetics Shambles 5: The evolution of cancer
Cancer is the second leading cause of death in humans globally. But the catch all term of ‘cancer’ is often misunderstood. So what exactly is this cell disease that impacts so many of our lives? How long has it been around? How does it spread? What is our current understanding of its evolution and …
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.
Episode 143: The Uromigos Paper of the Month - Determinants of anti- PD-1 response and resistance in clear cell renal cell carcinoma
Samra Turajlic describes her cancer cell paper.
Episode 94: EIKCS Summary of Day 1
Samra Turajlic summarised the meetings and looks forward to Day 2...
موتور جستجوی پادکست
می توانید از وب سایت ما برای جستجوی پادکست های3,821,549و قسمت های195,359,167بر اساس افراد، مکان ها یا موضوعات استفاده کنید.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
